How can we improve the provision of high quality care?     Join the Quality & Safety Community

43rd World UNION Conference on Lung Health
Kuala Lumpur, Malaysia 2012

Register now for “Preventing child deaths from drug resistant tuberculosis”
- A workshop hosted by Médecins Sans Frontières (MSF) and the Sentinel
Project on Pediatric Drug-Resistant Tuberculosis

Date: Wednesday November 14, 2012
Time: 09.00 – 12.30
Location: Kuala Lumpur Convention Centre, (room to be confirmed).
Workshop registration FREE with Conference registration

Chair: Steve Graham
Presentations, followed by discussion:
1. An introduction to the Sentinel Project on Pediatric DR-TB
Mercedes Becerra (USA)

2. Research meeting the needs of children with DR-TB: an update on progress
Soumya Swaminathan (India)

3. Introducing DR-TB diagnosis and treatment for children into TB
programmes: a case study from Tajikistan
Bern-Thomas Nyang'wa (UK)

4. The use of practical tools and approaches to the diagnosis and treatment
of children with DR-TB
James Seddon (UK)

5. Children in the evolving TB epidemic: future perspectives and priorities
Ben Marais (Australia)





Joanna Keenan
Press Officer
Médecins Sans Frontières - Access Campaign
E: joanna.keenan[at]geneva.msf.org
T: twitter.com/joanna_keenan

msfaccess.org
twitter.com/MSF_access
facebook.com/MSFaccess

 
Sophie Beauvais
Replied at 10:55 AM, 19 Oct 2012

Thanks for sharing Joanna. Also just received announcement for the below peds session at Union fyi:
---
Making markets work for tuberculosis: fostering a healthy micromarket for paediatric TB medicines through innovative market approaches

UNITAID-Sponsored Satellite Symposium
at the 43rd Union World Conference on Lung Health, Kuala Lumpur, Malaysia
Thursday 15 November 2012
5.00 – 6.30 pm
Kuala Lumpur Convention Centre, Plenary Theatre

Children with TB have consistently poor access to quality medicines tailored for their needs. Despite the urgent need for new child-friendly formulations, market barriers to innovation remain a challenge. Unclear regulatory pathways, product development challenges, and other serious obstacles require targeted intervention. This session will examine potential solutions and define new approaches to fostering a healthy, dynamic market for paediatric TB medicines.

Co-Chairs:
Melvin Spigelman, President and Chief Executive Officer, TB Alliance
Carol Nawina Nyirenda, Community Initiative for TB, HIV/AIDS & Malaria, Zambia

Presenters:
Stephen M. Graham, Chair, Child TB subgroup, WHO Stop TB Partnership, Setting the scene: urgent unmet needs in paediatric TB, and targets for future product development
Lisa Hedman, Technical Officer, Essential Medicines and Pharmaceutical Policies, WHO, Defining the hurdles: challenges in product development and paediatric regulatory pathway
David Ripin, Executive Vice President of Access Programs, Clinton Health Access Initiative, Aggregating demand and other ‘pull’ mechanisms: what has worked and where other tools are needed for paediatric TB
Janet Ginnard, Technical Officer, Market Dynamics, UNITAID, A donor perspective: activities to foster a healthy micromarket for paediatric TB medicines

To register for this side event please contact Fabienne Maertens at

UNITAID
World Health Organization - 20, avenue Appia
CH-1211 Geneva 27 - Switzerland
www.unitaid.eu

  Sign in to reply